Drug Shortage Report for IOPIDINE

Last updated on 2018-01-09

Report ID 24465
Drug Identification Number 00888354
Brand name IOPIDINE OPH SOL 1%
Common or Proper name APRACLONIDINE HCL
Company Name ALCON CANADA INC
Market Status MARKETED
Active Ingredient(s) APRACLONIDINE
Strength(s) 1%
Dosage form(s) LIQUID
Route of administration OPHTHALMIC
Packaging size (2 x 0.1mL) x 12
Anatomical Therapeutical Chemical (ATC) code S01EA
Anatomical Therapeutical Chemical (ATC) description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-10-03
Estimated end date 2018-01-24
Actual end date 2018-01-08
Shortage status Resolved
Updated date 2018-01-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address LANDIS + GYR-STRASSE 1
ZUG, --
SWITZERLAND 6300
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2018-01-09 English Compare
v8 2018-01-08 French Compare
v7 2018-01-08 English Compare
v6 2017-12-04 French Compare
v5 2017-12-04 English Compare
v4 2017-10-05 French Compare
v3 2017-10-05 English Compare
v2 2017-10-05 English Compare
v1 2017-10-05 English Compare

Showing 1 to 9 of 9